In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest
Identifieur interne : 000866 ( Main/Exploration ); précédent : 000865; suivant : 000867In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest
Auteurs : Yukihiko Shirayama [Japon] ; Toshio Yano [Japon] ; Kiyohisa Takahashi [Japon] ; Seizo Takahashi [Japon] ; Takashi Ogino [Japon]Source :
- European Journal of Neuroscience [ 0953-816X ] ; 2004-08.
English descriptors
Abstract
The 31P NMR localised method was used to study the metabolism of phospholipid and high energy phosphate in the prefrontal cortex. The spectra were taken from patients with schizophrenia (11 males) receiving neuroleptic medication, and were compared to normal controls (15 males). Their spectral intensities were analysed using a non‐linear least‐squares method with a prior knowledge of the fixed chemical shifts and linewidths, leading to further resolution into resonances of glycerophosphorylethanolamine (GPE), glycerophosphorylcholine (GPC), phosphorylethanolamine (PE) and phosphorylcholine (PC). The metabolite concentrations were calculated referring to the spectral intensities of phosphate phantoms with known concentrations. T1 values of phantom and cerebrum were estimated from a series of localised inversion recovery spectra to correct for the signal saturation effects. The schizophrenic patients showed an increased concentration of GPC but not GPE, PE or PC. Furthermore, no difference was observed regarding the concentration of high‐energy phosphates such as phosphocreatine, inorganic phosphate and ATP. The patients did not show any differences in mitochondrial function such as phosphorylation potential and the ratio of the rate of ATP synthesis. Thus, an increase in GPC concentration in the prefrontal cortex could be characteristic of the pathophysiology of schizophrenia with mild negative symptoms.
Url:
DOI: 10.1111/j.1460-9568.2004.03524.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001708
- to stream Istex, to step Curation: 001177
- to stream Istex, to step Checkpoint: 000395
- to stream Main, to step Merge: 000887
- to stream Main, to step Curation: 000866
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest</title><author><name sortKey="Shirayama, Yukihiko" sort="Shirayama, Yukihiko" uniqKey="Shirayama Y" first="Yukihiko" last="Shirayama">Yukihiko Shirayama</name></author><author><name sortKey="Yano, Toshio" sort="Yano, Toshio" uniqKey="Yano T" first="Toshio" last="Yano">Toshio Yano</name></author><author><name sortKey="Takahashi, Kiyohisa" sort="Takahashi, Kiyohisa" uniqKey="Takahashi K" first="Kiyohisa" last="Takahashi">Kiyohisa Takahashi</name></author><author><name sortKey="Takahashi, Seizo" sort="Takahashi, Seizo" uniqKey="Takahashi S" first="Seizo" last="Takahashi">Seizo Takahashi</name></author><author><name sortKey="Ogino, Takashi" sort="Ogino, Takashi" uniqKey="Ogino T" first="Takashi" last="Ogino">Takashi Ogino</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:574969D0DB1DC890E159FBD7A02D51F95D205886</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1111/j.1460-9568.2004.03524.x</idno><idno type="url">https://api.istex.fr/document/574969D0DB1DC890E159FBD7A02D51F95D205886/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001708</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001708</idno><idno type="wicri:Area/Istex/Curation">001177</idno><idno type="wicri:Area/Istex/Checkpoint">000395</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000395</idno><idno type="wicri:doubleKey">0953-816X:2004:Shirayama Y:in:vivo:p</idno><idno type="wicri:Area/Main/Merge">000887</idno><idno type="wicri:Area/Main/Curation">000866</idno><idno type="wicri:Area/Main/Exploration">000866</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest</title><author><name sortKey="Shirayama, Yukihiko" sort="Shirayama, Yukihiko" uniqKey="Shirayama Y" first="Yukihiko" last="Shirayama">Yukihiko Shirayama</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Psychiatry, National Center Hospital for Mental, Nervous and Muscular Disorders, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–0031</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–8502</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Yano, Toshio" sort="Yano, Toshio" uniqKey="Yano T" first="Toshio" last="Yano">Toshio Yano</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Psychiatry, National Center Hospital for Mental, Nervous and Muscular Disorders, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–0031</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–8502</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Takahashi, Kiyohisa" sort="Takahashi, Kiyohisa" uniqKey="Takahashi K" first="Kiyohisa" last="Takahashi">Kiyohisa Takahashi</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Psychiatry, National Center Hospital for Mental, Nervous and Muscular Disorders, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–0031</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Takahashi, Seizo" sort="Takahashi, Seizo" uniqKey="Takahashi S" first="Seizo" last="Takahashi">Seizo Takahashi</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–8502</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Chemical and Biological Sciences, Faculty of Science, Japan Women's University, Mejiro, Tokyo 112–8681</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Ogino, Takashi" sort="Ogino, Takashi" uniqKey="Ogino T" first="Takashi" last="Ogino">Takashi Ogino</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4‐1‐1 Ogawahigashi, Kodaira, Tokyo 187–8502</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neuroscience</title><idno type="ISSN">0953-816X</idno><idno type="eISSN">1460-9568</idno><imprint><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2004-08">2004-08</date><biblScope unit="volume">20</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="749">749</biblScope><biblScope unit="page" to="756">756</biblScope></imprint><idno type="ISSN">0953-816X</idno></series><idno type="istex">574969D0DB1DC890E159FBD7A02D51F95D205886</idno><idno type="DOI">10.1111/j.1460-9568.2004.03524.x</idno><idno type="ArticleID">EJN3524</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0953-816X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>magnetic resonance spectroscopy</term><term>phosphorus metabolism</term><term>schizophrenia</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 31P NMR localised method was used to study the metabolism of phospholipid and high energy phosphate in the prefrontal cortex. The spectra were taken from patients with schizophrenia (11 males) receiving neuroleptic medication, and were compared to normal controls (15 males). Their spectral intensities were analysed using a non‐linear least‐squares method with a prior knowledge of the fixed chemical shifts and linewidths, leading to further resolution into resonances of glycerophosphorylethanolamine (GPE), glycerophosphorylcholine (GPC), phosphorylethanolamine (PE) and phosphorylcholine (PC). The metabolite concentrations were calculated referring to the spectral intensities of phosphate phantoms with known concentrations. T1 values of phantom and cerebrum were estimated from a series of localised inversion recovery spectra to correct for the signal saturation effects. The schizophrenic patients showed an increased concentration of GPC but not GPE, PE or PC. Furthermore, no difference was observed regarding the concentration of high‐energy phosphates such as phosphocreatine, inorganic phosphate and ATP. The patients did not show any differences in mitochondrial function such as phosphorylation potential and the ratio of the rate of ATP synthesis. Thus, an increase in GPC concentration in the prefrontal cortex could be characteristic of the pathophysiology of schizophrenia with mild negative symptoms.</div></front></TEI><affiliations><list><country><li>Japon</li></country><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><noRegion><name sortKey="Shirayama, Yukihiko" sort="Shirayama, Yukihiko" uniqKey="Shirayama Y" first="Yukihiko" last="Shirayama">Yukihiko Shirayama</name></noRegion><name sortKey="Ogino, Takashi" sort="Ogino, Takashi" uniqKey="Ogino T" first="Takashi" last="Ogino">Takashi Ogino</name><name sortKey="Shirayama, Yukihiko" sort="Shirayama, Yukihiko" uniqKey="Shirayama Y" first="Yukihiko" last="Shirayama">Yukihiko Shirayama</name><name sortKey="Takahashi, Kiyohisa" sort="Takahashi, Kiyohisa" uniqKey="Takahashi K" first="Kiyohisa" last="Takahashi">Kiyohisa Takahashi</name><name sortKey="Takahashi, Seizo" sort="Takahashi, Seizo" uniqKey="Takahashi S" first="Seizo" last="Takahashi">Seizo Takahashi</name><name sortKey="Takahashi, Seizo" sort="Takahashi, Seizo" uniqKey="Takahashi S" first="Seizo" last="Takahashi">Seizo Takahashi</name><name sortKey="Yano, Toshio" sort="Yano, Toshio" uniqKey="Yano T" first="Toshio" last="Yano">Toshio Yano</name><name sortKey="Yano, Toshio" sort="Yano, Toshio" uniqKey="Yano T" first="Toshio" last="Yano">Toshio Yano</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/NickelMaghrebV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000866 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000866 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= NickelMaghrebV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:574969D0DB1DC890E159FBD7A02D51F95D205886
|texte= In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest
}}
| This area was generated with Dilib version V0.6.27. |  |